RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy
Abstract Background Facioscapulohumeral dystrophy (FSHD) is caused by mutations leading to the aberrant expression of the DUX4 transcription factor in muscles. DUX4 was proposed to induce cell death, but the involvement of different death pathways is still discussed. A possible pro‐apoptotic role of...
Saved in:
Main Authors: | Virginie Mariot (Author), Romain Joubert (Author), Laura Le Gall (Author), Eva Sidlauskaite (Author), Christophe Hourde (Author), William Duddy (Author), Thomas Voit (Author), Maximilien Bencze (Author), Julie Dumonceaux (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy
by: Virginie Mariot, et al.
Published: (2020) -
Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy
by: Linde F. Bouwman, et al.
Published: (2021) -
p53-independent DUX4 pathology in cell and animal models of facioscapulohumeral muscular dystrophy
by: Darko Bosnakovski, et al.
Published: (2017) -
Adenine base editing of the DUX4 polyadenylation signal for targeted genetic therapy in facioscapulohumeral muscular dystrophy
by: Darina Šikrová, et al.
Published: (2021) -
Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models
by: Andreia M. Nunes, et al.
Published: (2021)